Valiglurax
Valiglurax (VU2957), also known as VU0652957 and VU2957, is a potent, selective, CNS penetrant, and orally bioavailable mGlu4 PAM. VU2957 possessed attractive in vitro and in vivo pharmacological and DMPK properties across species. VU2957 was evaluated as a preclinical development candidate for the treatment of Parkinson’s disease.
Product Specifications
CAS Number
1976050-09-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
329.28
Molecular Formula
C16H10F3N5
Notes
Research use only, not for human use.
Receptor
GluR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
B0077-04 50 µg
BAP31 (B Cell Receptor-Associated Protein 31, BCR-Associated Protein, p28, CDM Protein, 6C6-AG Tumor-associated Antigen, DXS1357E) discontinued
Ask
View Details